Vir Bio 8-K Filing
Vir Biotechnology files 8-K with SEC, disclosing executive changes and shareholder vote results. The filing includes updates on compensatory arrangements for certain officers.
Filed: 2026-05-28 AccNo: 0001628280-26-038630 Size: 186 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders